OBJECTIVE: Progression of neointimal stent coverage (NSC) and changes in thrombus were evaluated serially by coronary angioscopy for up to 2 years after sirolimus-eluting stent (SES) implantation. METHODS: Serial angioscopic observations were performed in 20 segments of 20 patients at baseline, at 6 months and at 2 years after SES implantation. NSC was classified as follows: 0, uncovered struts; 1, visible struts through thin neointima; or 2, no visible struts. In each patient, maximum and minimum NSC was evaluated. Existence of thrombus was also examined. RESULTS: The maximum NSC increased from 6 months to 2 years (mean (SD) 1.2 (0.4) vs 1.8 (0.4), respectively, p = 0.005), while the minimum NSC did not change (0.7 (0.5) vs 0.8 (0.4), respectively, p = 0.25). The prevalence of patients with uncovered struts did not decrease from 6 months to 2 years (35% vs 20%, respectively, p = 0.29). Although there were no thrombus-related adverse events, new thrombus formation was found in 5% of 6-month, and in 20% of 2-year follow-up evaluations. The prevalence of thrombus inside the SES at baseline, 6 months and 2 years was similar (40%, 40% and 30%, respectively; p = NS). CONCLUSIONS: Neointimal growth inside the SES progressed heterogeneously. Uncovered struts persisted in 20% of the patients for up to 2 years and subclinical thrombus formation was not uncommon.
OBJECTIVE: Progression of neointimal stent coverage (NSC) and changes in thrombus were evaluated serially by coronary angioscopy for up to 2 years after sirolimus-eluting stent (SES) implantation. METHODS: Serial angioscopic observations were performed in 20 segments of 20 patients at baseline, at 6 months and at 2 years after SES implantation. NSC was classified as follows: 0, uncovered struts; 1, visible struts through thin neointima; or 2, no visible struts. In each patient, maximum and minimum NSC was evaluated. Existence of thrombus was also examined. RESULTS: The maximum NSC increased from 6 months to 2 years (mean (SD) 1.2 (0.4) vs 1.8 (0.4), respectively, p = 0.005), while the minimum NSC did not change (0.7 (0.5) vs 0.8 (0.4), respectively, p = 0.25). The prevalence of patients with uncovered struts did not decrease from 6 months to 2 years (35% vs 20%, respectively, p = 0.29). Although there were no thrombus-related adverse events, new thrombus formation was found in 5% of 6-month, and in 20% of 2-year follow-up evaluations. The prevalence of thrombus inside the SES at baseline, 6 months and 2 years was similar (40%, 40% and 30%, respectively; p = NS). CONCLUSIONS: Neointimal growth inside the SES progressed heterogeneously. Uncovered struts persisted in 20% of the patients for up to 2 years and subclinical thrombus formation was not uncommon.
Authors: Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys Journal: Lancet Date: 2004 Oct 23-29 Impact factor: 79.321
Authors: Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser Journal: J Am Coll Cardiol Date: 2006-11-02 Impact factor: 24.094
Authors: Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani Journal: J Am Coll Cardiol Date: 2006-05-05 Impact factor: 24.094
Authors: Peter Wenaweser; Janine Dörffler-Melly; Katja Imboden; Stephan Windecker; Mario Togni; Bernhard Meier; Andre Haeberli; Otto M Hess Journal: J Am Coll Cardiol Date: 2005-06-07 Impact factor: 24.094
Authors: Aloke V Finn; Michael Joner; Gaku Nakazawa; Frank Kolodgie; John Newell; Mike C John; Herman K Gold; Renu Virmani Journal: Circulation Date: 2007-04-16 Impact factor: 29.690
Authors: Joost Daemen; Peter Wenaweser; Keiichi Tsuchida; Linda Abrecht; Sophia Vaina; Cyrill Morger; Neville Kukreja; Peter Jüni; Georgios Sianos; Gerrit Hellige; Ron T van Domburg; Otto M Hess; Eric Boersma; Bernhard Meier; Stephan Windecker; Patrick W Serruys Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Gaku Nakazawa; Fumiyuki Otsuka; Masataka Nakano; Marc Vorpahl; Saami K Yazdani; Elena Ladich; Frank D Kolodgie; Aloke V Finn; Renu Virmani Journal: J Am Coll Cardiol Date: 2011-03-15 Impact factor: 24.094
Authors: Hong Sang Choi; Myung Ho Jeong; Il Kook Seo; Min Goo Lee; Jum Suk Ko; Keun Ho Park; Doo Sun Sim; Nam Sik Yoon; Kye Hun Kim; Hyung Wook Park; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang Journal: Korean Circ J Date: 2011-07-30 Impact factor: 3.243